Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
29 Leser
Artikel bewerten:
(0)

Global Atopic Dermatitis Treatment Market - Industry Forecast to 2025 - By Mode of Administration, Distribution Channel, Drug Type & Geography

DUBLIN, July 25, 2017 /PRNewswire/ --

The "Global Atopic Dermatitis Treatment Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The Global Atopic Dermatitis Treatment Market is poised to grow at a CAGR of around 14.1% over the next decade to reach approximately $179.81 billion by 2025. Some of the prominent trends that the market is witnessing include rising R&D focus on novel biologics, recent technological developments in atopic dermatitis treatment and growth opportunities/investment opportunities.

Based on mode of administration the market is categorized into injectable, topical and oral. Depending on the distribution channel the market is segmented by mail order pharmacies, hospital pharmacies, online pharmacies, drug stores, retail pharmacies and dermatology clinics.

By drug type, market is segregated by Immunosuppressants, PDE-4 Inhibitor, Antihistamines, Antibiotics, Biologic Therapy, Calcineurin Inhibitors, Corticosteroids and Emollients.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Current Trends:

  • Rising R&D focus on novel biologics
  • Recent technological developments in Atopic dermatitis treatment

Companies Mentioned

  • Velite Pharmaceutical
  • Galderma SA
  • Pfizer
  • Fujisawa Healthcare
  • Dow Pharm
  • Regeneron Pharmaceuticals
  • LEO Pharma
  • Sanofi SA
  • Novartis
  • Bristol-Myers Squibb
  • Bayer AG
  • Meda Pharmaceuticals
  • Anacor Pharmaceutical Inc.
  • Connetics Corporation
  • Allergan Plc.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 Atopic Dermatitis Treatment Market, By Mode Of Administration

5 Atopic Dermatitis Treatment Market, By Distribution Channel

6 Atopic Dermatitis Treatment Market, By Drug Type

7 Atopic Dermatitis Treatment Market, By Geography

8 Key Player Activities

9 Leading Companies

For more information about this report visit https://www.researchandmarkets.com/research/rps99s/global_atopic

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.